 |
市場調查報告書
商品編碼
2077210
癌症疫苗市場：按疫苗類型、癌症類型、應用和地區分類。Cancer Vaccines Market, By Vaccine Type, By Cancer Type, By Application, By Geography |
||||||
價格
簡介目錄
預計到2026年，癌症疫苗市場規模將達到74.6億美元，到2033年將達到142.6億美元。預計從2026年到2033年，其複合年成長率將達到9.7%。
| 分析範圍 | 分析詳情 | ||
|---|---|---|---|
| 基準年 | 2025 | 市場規模（2026 年） | 74.6億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2026-2033 |
| 預測期（2026-2033 年）複合年成長率 | 9.70% | 預計金額（2033 年） | 142.6億美元 |
全球癌症疫苗市場涵蓋多種疫苗類型，包括治療性疫苗、預防性疫苗和聯合疫苗，並供應給醫院、癌症治療中心、研究機構和居家醫療機構。這些產品被多個終端用戶產業及其他領域廣泛採用，有助於提高效率、效能和可靠性。這些領域應用範圍的擴大，以及持續的產品創新，將持續推動市場成長。
市場動態：
關鍵應用領域需求的成長、對效率和性能日益重視以及持續的產品創新，預計將是推動全球癌症疫苗市場成長的主要因素。主要終端用戶接受度的提高以及對先進解決方案投資的增加，也將進一步促進市場擴張。
例如，供應商正日益開發針對醫院、癌症治療中心及相關應用的客製化產品和服務。此外，持續的研發投入和新技術的整合預計將在預測期內為市場參與者創造新的成長機會。
本報告的主要特點
- 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
- 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
- 本節根據各種參數（公司概況、產品系列、主要趨勢、財務表現、策略等）對全球癌症疫苗市場的主要公司進行介紹。
- 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
- 《全球癌症疫苗市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過分析全球癌症疫苗市場中使用的各種策略矩陣來促進決策。
目錄
第1章：分析目標與假設
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 市場機遇
- 影響分析
- 近期產品發布
- 流行病學
- 企業合併、商業合作
- 監管趨勢
- 主要進展
- PEST分析
- 商業夥伴關係場景
- 品牌和定價分析
- 銷售代理情況
- 波特五力分析
- 技術進步
- 主要進展
- 市場趨勢
- 前景
- 主要公司：按銷售收入
第4章：癌症疫苗市場：依疫苗類型分類（2026-2033 年）
- 治療
- 為了預防
- 複雜類型
- 其他
第5章：癌症疫苗市場：依癌症類型分類（2026-2033 年）
- 肺癌
- 乳癌
- 皮膚癌
- 子宮頸癌
- 其他
第6章：癌症疫苗市場：依應用領域分類（2026-2033年）
- 醫院及癌症治療中心
- 研究機構
- 居家醫療
- 其他
第7章 癌症疫苗市場：按地區分類（2026-2033 年）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 比荷盧經濟聯盟
- 丹麥
- 挪威
- 瑞典
- 其他歐洲國家
- 亞太地區
- 中國
- 台灣
- 印度
- 日本
- 印尼
- 馬來西亞
- 菲律賓
- 新加坡
- 澳洲
- 韓國
- 其他亞太國家
- 中東和非洲
- 巴林
- 科威特
- 阿曼
- 卡達
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 北非
- 中非
- 其他中東國家
第8章 競爭情勢
- BioVaxTech
- ImmunoGenix
- ProMedica Therapeutics
- NeoVax Bio
- CelluVax Inc.
- OncoVax Solutions
- MedGene Biologics
- ViroThera LLC
- Genetix Pharmaceuticals
- ImmuneFocus
- NanoVax Corp
- OncoShot Biotech
第9章
- 分析方法
- 關於 Coherent Market Insights
簡介目錄
Product Code: CMI1209
Cancer Vaccines Market is estimated to be valued at USD 7.46 billion in 2026 and is expected to reach USD 14.26 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.46 billion |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.70% | 2033 Value Projection: | USD 14.26 billion |
The global cancer vaccines market comprises vaccine type categories such as Therapeutic, Prophylactic, and Combined, serving applications including Hospitals & Oncology Centers, Research Institutes, and Homecare Settings. These offerings are adopted across multiple end-use sectors and other areas, where they support improved efficiency, performance, and reliability. Growing adoption across these segments, combined with ongoing product innovation, continues to support expansion of the market.
Market Dynamics:
Rising demand across key application areas, increasing emphasis on efficiency and performance, and continued product innovation are major factors expected to drive growth of the global cancer vaccines market. Expanding adoption among major end users and growing investment in advanced solutions are further supporting market expansion.
For instance, providers are increasingly developing offerings tailored to Hospitals & Oncology Centers and related applications. Moreover, ongoing research and development, along with the integration of new technologies, is expected to create new growth opportunities for market players over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cancer vaccines market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include BioVaxTech; ImmunoGenix; ProMedica Therapeutics; NeoVax Bio; CelluVax Inc.; OncoVax Solutions; MedGene Biologics; ViroThera LLC; Genetix Pharmaceuticals; ImmuneFocus; NanoVax Corp.; OncoShot Biotech, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cancer vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer vaccines market.
Detailed Segmentation:
- Global Cancer Vaccines Market, By Vaccine Type (Revenue, USD Bn, 2021 - 2033)
- Therapeutic
- Prophylactic
- Combined
- Others
- Global Cancer Vaccines Market, By Cancer Type (Revenue, USD Bn, 2021 - 2033)
- Lung Cancer
- Breast Cancer
- Skin Cancer
- Cervical Cancer
- Others
- Global Cancer Vaccines Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Hospitals & Oncology Centers
- Research Institutes
- Homecare Settings
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- BioVaxTech; ImmunoGenix; ProMedica Therapeutics; NeoVax Bio; CelluVax Inc.; OncoVax Solutions; MedGene Biologics; ViroThera LLC; Genetix Pharmaceuticals; ImmuneFocus; NanoVax Corp.; OncoShot Biotech*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Cancer Type
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Partnership Scenario
- Brand and Pricing Analysis
- Distributors Landscape
- Porters Analysis
- Technological Advancements
- Key Developments
- Market Trend
- Future Prospective
- Top Market Players by Revenue
4. Cancer Vaccines Market, By Vaccine Type, 2026-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Therapeutic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Prophylactic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Combined
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
5. Cancer Vaccines Market, By Cancer Type, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Skin Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Cervical Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
6. Cancer Vaccines Market, By Application, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals & Oncology Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
7. Cancer Vaccines Market, By Region, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Benelux
- Denmark
- Norway
- Sweden
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- China
- Taiwan
- India
- Japan
- Indonesia
- Malaysia
- Philippines
- Singapore
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- UAE
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of Middle East
8. Competitive Landscape
- BioVaxTech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ImmunoGenix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ProMedica Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NeoVax Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CelluVax Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OncoVax Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MedGene Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ViroThera LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genetix Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ImmuneFocus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NanoVax Corp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OncoShot Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
02-2729-4219
+886-2-2729-4219
肽類癌症疫苗市場：依研發階段、應用和地區分類
癌症疫苗市場：2026-2032年全球市場預測（依產品類型、劑型、給藥途徑、治療策略、疾病分期、適應症及最終用戶分類）
癌症疫苗市場規模、佔有率和成長分析：按疫苗類型、技術、適應症、最終用戶和地區分類－2026-2033年產業預測
癌症疫苗市場報告：按類型、技術、適應症、最終用戶和地區分類（2026-2034 年）
全球癌症疫苗市場規模、佔有率、趨勢和成長分析報告（2026-2034年）癌症疫苗市場規模、佔有率、成長及全球產業分析：按類型、應用和地區分類，並預測至2026-2034年
癌症疫苗市場規模、佔有率和趨勢分析報告：按疫苗類型、適應症類型、技術類型、地區和細分市場預測（2026-2033 年）全球膀胱癌疫苗市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測（2026-2034）DNA癌症疫苗的全球市場:臨床試驗，開發技術平台，市場機會預測(2026年)胜肽癌症疫苗的全球市場:市場機會，技術平台，臨床試驗趨勢(2030年)
▼